Similar Articles |
|
The Motley Fool July 27, 2011 |
Integra LifeSciences Holdings Earnings Preview Integra LifeSciences Holdings will unveil its latest earnings Thursday. |
The Motley Fool May 9, 2005 Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool October 31, 2005 Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool March 6, 2006 Stephen D. Simpson |
Integrating Integra's Numbers: Fool by Numbers Integra LifeSciences released fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool August 2, 2006 Stephen D. Simpson |
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. |
The Motley Fool May 8, 2006 Stephen D. Simpson |
Integra Adds Another Piece The jigsaw puzzle gets larger at Integra Lifesciences, but does it get better? Investors, this company has treated its shareholders rather well. |
The Motley Fool November 3, 2006 Matthew Crews |
Integra's Value of Growth Whenever a company earns less than its cost of capital, it destroys value. No amount of adjustments can hide the simple fact that Integra is unable to create value for its shareholders. |
The Motley Fool March 6, 2006 Stephen D. Simpson |
Integra Integrates Higher Revenue High rewards will match high expectations -- if the medical device company delivers. Investors, take note. |
The Motley Fool November 3, 2006 |
Integra's Improving Revenues: Fool by Numbers Integra LifeSciences released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool January 6, 2012 Sean Williams |
Integra LifeSciences Shares Plunged: What You Need to Know Shareholders of medical device maker Integra LifeSciences are falling off their second cliff in as many quarters, down 17%, after the company issued disappointing preliminary fourth-quarter and full-year guidance. |
The Motley Fool October 21, 2004 Rich Duprey |
K2 Slays the Competition Sporting goods manufacturer reports soaring sales, profits, and margins. |
The Motley Fool March 1, 2007 |
Sewing Up Integra Lifesciences: Fool by Numbers The medical-device specialist released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool October 13, 2004 Rich Duprey |
How to Spot a Serial Acquirer Acquisitions can juice sales but can also lead to messy balance sheets. A simple test can sort them out. |
The Motley Fool October 31, 2011 Travis Hoium |
Integra LifeSciences Shares Dropped: What You Need to Know Shares of medical device maker Integra LifeSciences fell 14% today after the company released earnings and cut its full-year forecast. |
The Motley Fool June 20, 2005 Richard Gibbons |
Think Like a Dealmaker Acquisitions can be great for investors. Here's how to identify acquisition targets before deals are announced. |
InternetNews February 17, 2010 |
Tech Sector's M&A Climate Improving: Study Search, security and cloud computing are three of the most attractive markets for mergers and acquisitions in 2010 according to the latest study by PricewaterhouseCoopers. |
The Motley Fool February 6, 2007 |
Edwards Lifesciences Gets a Life: Fool by Numbers The cardiovascular treatment company released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool July 25, 2006 Ryan Fuhrmann |
A Steady Heartbeat at Edwards Can Edwards Lifesciences grow enough to justify its stock price? |
The Motley Fool February 4, 2011 Seth Jayson |
Does Edwards Lifesciences Measure Up? With recent TTM operating margins exceeding historical averages, Edwards Lifesciences looks like it's doing fine. |
InternetNews January 6, 2011 |
Microsoft Loses Two Acquisition Execs Microsoft bids farewell to two leaders of its mergers and acquisitions division, including the executive who was enmeshed in the company's effort to purchase Yahoo in 2008. |
Financial Planning February 1, 2005 John J. Bowen |
Purchasing Power If you want to expand your financial advisory business by acquiring another firm, look before you leap. |
The Motley Fool February 26, 2004 Dave Marino-Nachison |
Engineered Support's System Solid profit margins and successful acquisitions are helping the military contractor grow. |
The Motley Fool May 27, 2011 Andrew Tonner |
Does Zimmer Holdings Deserve a Spot in Your Portfolio? Compared to it's peers, Zimmer Holdings doesn't look like a stock for your portfolio right now. |
The Motley Fool November 11, 2008 Brian Orelli |
AOB Is A-OK Growing through acquisitions seems to be working. |
Finance & Development March 1, 2001 Ashoka Mody & Shoko Negishi |
Cross-Border Mergers and Acquisitions in East Asia: Trends and Implications Mergers and acquisitions across national borders have increased in East Asia since the onset of the financial crisis. What has caused this new wave of mergers and acquisitions and what advantages might they offer to the region's financially distressed economies? |
The Motley Fool August 30, 2005 Nathan Parmelee |
Is Electronics Boutique's Strategy Sound? The video game software and hardware retailer shows revenue growth, but profits don't follow the same trend. Are the acquisitions worth it? Investors, take note. |
The Motley Fool May 28, 2011 Eric Bleeker |
Are Microsoft's Investments in Its Future Paying Off? Taking a peek behind how Microsoft innovates. |
The Motley Fool September 28, 2011 Alex Dumortier |
Edwards Lifesciences: Creating or Destroying Value? With shares trading at 33.2 times its earnings-per-share estimate for the next 12 months, the share buyback program looks like a poor use of shareholder capital at these prices. |